Functional food ingredient – chromium complex with protein fermentolysate of bivalve Mactra chinensis for the prevention of hyperlipidemia and obesity

Abstract

The creation of specialized food systems capable of correcting body weight and influencing lipid metabolism is an urgent task at the present stage. The main way to create such food systems is to modify product profiles (lipid, protein, carbohydrate, mineral, vitamin, etc.).

The aim of the study was to obtain and characterize a new food source of an organic form of chromium for the prevention

of hyperlipidemia and obesity in the form of a complex with peptide fractions of fermentolysate proteins of the Mactra chinensis bivalve mollusk from the Far Eastern region.

Material and methods. Soft food parts of the Mactra chinensis bivalve mollusk from the Far Eastern region (the motor muscle and mantle) were used as objects of research. Mollusk specimens were collected in the Amur Bay in June – September 2022. Biotechnological modification of soft tissue proteins was carried out using alkaline protease protozyme B with the following parameters: the duration of the process – 12 and 24 hours, pH – 7.0–7.2, temperature 55 °C. The fractional composition of proteins and peptides was determined by medium pressure gel permeation chromatography, the molecular weight (MW) of proteins and peptides was calculated using MW markers by comparing retention volumes. Extraction of free amino acids was carried out with 70% ethanol for 24 hours at a temperature of 20 °C, the composition and quantitative content of amino acids were determined by HPLC. The complexation reaction was carried out by adding to the fermentolysate with stirring a 10% aqueous solution of CrCl3×6H2O in a mass ratio of 6.25 × nitrogen in the liquid fraction : chromium (III) chloride = 20:1. Process conditions: temperature 20–25 °C, time 60 min, pH 7.0–7.1. The chromium content was determined by the atomic absorption method using spectrophotometer.

Results. The content of low-molecular fractions increased more significantly over time in the mantle fermentolysate. The content of the high-molecular fraction of peptides weighing more than 160 kDa was minimal for both the muscle and the mantle and didn’t exceed 1.1%. Low-molecular fractions weighing no more than 18 kDa in the 24-hour fermentolysate accounted for 79.6% for the muscle and 86.9% for the mantle. The obtained fermentolysates were characterized by a high content of the biologically active amino acid taurine – 25.9% (muscle) and 30.05% (mantle) of the total amino acid content. The high content of such essential amino acids as glycine, alanine, leucine, lysine, and the conditionally essential amino acid arginine was also determined. The obtained fermentolysates of soft tissue proteins of the Mactra chinensis were characterized by a fairly balanced amino acid composition. It has been experimentally established that more than 84% of the total chromium content in muscle fermentolysate and 80.9% in mantle fermentolysate was associated with peptide fractions with molecular weights from 24 to 1.4 kDa, and the highest specific chromium content – 1.67 mg/g protein (muscle) and 1.58 mg/g protein (mantle) was determined in the interval fractions with molecular weights of 18.0–12.5 kDa. The minimum specific content of the trace element was established for high-molecular fractions of 160–67 kDa and low-molecular fraction weighing less than 1.4 kDa.

Conclusion. Biotechnological modification of soft tissue proteins of the Mactra chinensis bivalve mollusk from the Far Eastern region made it possible to obtain a balanced amino acid composition fermentolysate with a high content of the free biologically active amino acid taurine. Fortification of the obtained fermentolysate with chromium demonstrated high efficiency of its binding to the amino acid and peptide matrices of the protein hydrolysate. The chromium complex with fermentolysate of proteins of the Mactra chinensis bivalve mollusk can be used as a food source of chromium and taurine, including as a functional ingredient in special food systems for the prevention of hyperlipidemia and obesity.

Keywords:chromium; taurine; fermentolysate; Mactra chinensis mollusc; peptide fractions; hyperlipidemia; obesity

Funding. The work was carried out with the financial support of the Russian Science Foundation (grant 22-76-00008).

Conflict of interest. The authors declare no conflict of interest.

Contribution. The authors declare an equal contribution in the preparation of the article.

For citation: Tabakaev A.V., Tabakaeva O.V., Shchelkanov M.Yu. Functional food ingredient – chromium complex with protein fermentolysate of bivalve Mactra chinensis for the prevention of hyperlipidemia and obesity. Voprosy pitaniia [Problems of Nutrition]. 2023; 92 (2): 43–52. DOI: https://doi.org/10.33029/0042-8833-2023-92-2-43-52 (in Russian)

References

1. WHO Obesity and overweight. 2020. URL: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

2. Report of Rospotrebnadzor “On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2019”. URL: https://asko-med.ru/uploadStatereport%20rospotrebnadzor%202019.pdf (in Russian)

3. Zhernakova Yu.V., Zheleznova E.A., Chazova I.E. The prevalence of abdominal obesity in the subjects of the Russian Federation and its relationship with socio-economic status, the results of an epidemiological study of ESSAY-RF. Terapevticheskiy arkhiv [Therapeutic Archive]. 2018; 90 (10): 14–22. DOI. https://doi.org/10.26442/terarkh2018901014-22. (in Russian)

4. Kurmangulov A.A., Doroneva E.F., Troshina I.A., Petrova Yu.A., Golubeva T.I. Effects of inclusion of dietary fiber in the diet in obesity. Ozhirenie i metabolism [Obesity and Metabolism]. 2018; 15 (2): 35–9. DOI: https://doi.org/10.14341/OMET8785 (in Russian)

5. Makarem N., Mossavar-Rahmani Y., Sotres-Alvarez D., Hua S., Wong W.W., Van Horn L., et al. The relation between polyphenols and body composition in US Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Study of Latinos Nutrition and Physical Activity Assessment Study (SOLNAS). Curr Dev Nutr. 2017; 1 (11): e001115. DOI: https://doi.org/10.3945/cdn.117.001115

6. Beketova N.A., Kodentsova V.M., Derbeneva S.A., Kosheleva O.V., Pereverzeva O.G., Vrzhesinskaya O.A., et al. Vitamin status of patients with cardiovascular diseases and overweight or obesity. Voprosy pitaniia [Problems of Nutrition]. 2015; 84 (S5): 17. (in Russian)

7. Reutina S.V. The role of chromium in the human body. Vestnik RUDN. Seriya: Ekologiya i bezopasnost’ zhiznedeaytel’nosti [Bulletin of the RUDN. Series: Ecology and Life Safety]. 2009; (4): 50–55. (in Russian)

8. Kuryl T., Debski B., Martinik K. The effect of microelements supplementation on beta-oxidation activity in healthy and type 1 diabetic rats. Cent Eur J Public Health. 2008; 16 (4): 205–8. DOI: https://doi.org/10.21101/cejph.a3459

9. Popova A.Yu., Tutelyan V.A., Nikityuk D.B. On the new (2021) Norms of physiological requirements in energy and nutrients of various groups of the population of the Russian Federation. Voprosy pitaniia [Problems of Nutrition]. 2021; 90 (4): 6–19. DOI: https://doi.org/10.33029/0042-8833-2021-90-4-6-19 (in Russian)

10. Lau F.C., Bagchi M., Sen C.K., Bagchi D. Nutrigenomic basis of beneficial effects of chromium (III) on obesity and diabetes. Mol Cell Biochem. 2008; 317 (1–2): 1–10. DOI: https://doi.org/10.1007/s11010-008-9744-2

11. Tuzcu M., Sahin N., Orhan C., Agca C.A., Akdemir F., Tuzcu Z., et al. Impact of chromium histidinate on high fat diet induced obesity in rats. Nutr Metab (Lond). 2011; 8: 28. DOI: https://doi.org/10.1186/1743-7075-8-28

12. Maret W. Chromium supplementation in human health, metabolic syndrome, and diabetes. In: Essential Metals in Medicine: Therapeutic Use and Toxicity of Metal Ions in the Clinic. Berlin, Germany: De Gruyter, 2019: 231–52. DOI: https://doi.org/10.1515/9783110527872-015

13. White P.E., Vincent J.B. Systematic review of the effects of chromium (III) on chickens. Biol Trace Elem Res. 2019; 188: 99–126. DOI: https://doi.org/10.1007/s12011-018-1575-8

14. Bunting L.D., Tarifa T.A., Crochet B.T., Fernandez J.M., Depew C.L., Lovejoy J.C. Effects of dietary inclusion of chromium propionate and calcium propionate on glucose disposal and gastrointestinal development in dairy calves. J Dairy Sci. 2000; 83 (11): 2491–8. DOI: https://doi.org/10.3168/jds.S0022-0302(00)75141-1

15. McNamara J.P., Valdez F. Adipose tissue metabolism and production responses to calcium propionate and chromium propionate. J Dairy Sci. 2005; 88 (7): 2498–507. DOI: https://doi.org/10.3168/jds.S0022-0302(05)72927-1

16. Lai M.H., Chen Y.Y., Cheng H.H. Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin induced diabetic rats. Int J Vitam Nutr Res. 2006; 76 (6): 391–7. DOI: https://doi.org/10.1024/0300-9831.76.6.391

17. Asbaghi O., Naeini F., Ashtary-Larky D., Moradi S., Zakeri N., Eslampour E., et al. Effects of chromium supplementation on lipid profile in patients with type 2 diabetes: A systematic review and dose-response meta-analysis of randomized controlled trials. J Trace Elem Med Biol. 2021; 66: 126741. DOI: https://doi.org/10.1016/j.jtemb.2021.126741

18. Inanc N., Uyanik F., Sahin H., Yaman H., Erdem O. Effects of chromium supplementation on body composition, leptin, ghrelin levels and selected biochemical parameters in obese women. Trace Elem Electrolytes. 2006; 23 (2): 128–33. DOI: https://doi.org/10.5414/TEP23128

19. Zorin S.N., Sidorova Yu.S., Lobanova Yu.N., Maso V.K. An organic source of vanadium. Preparation and physico-chemical characterization. Voprosy pitaniia [Problems of Nutrition]. 2019; 88 (1): 85–90. DOI: https://doi.org/10.24411/0042-8833-2019-10010 (in Russian)

20. Zorin S.N., Sidorova Yu.S., Pleten’ A.P., Mazo V.K. Complexes of copper, manganese and chromium with enzymatic hydrolysate of pig spleen: An in vitro study. Voprosy pitaniia [Problems of Nutrition]. 2016; 85 (1): 81–4. DOI: https://doi.org/10.24411/0042-8833-2016-00010 (in Russian)

21. Mazo V.K., Abramova L.S., Zorin S.N. Food chelate complex (variants). Patent for invention RU 2376892 C1, 27.12.2009. Application No. 2008132570/13 dated 08.08.2008. (in Russian)

22. Zorin S.N. Enzymatic hydrolysates of food proteins and organic complexes of essential trace elements based on them. Voprosy pitaniia [Problems of Nutrition]. 2009; 78 (6): 60–6. (in Russian)

23. Zorin S.N., Bayarzhargal M., Gmoshinsky I.V., Mazo V.K. Complex assessment of organic forms of essential trace elements of zinc, copper, manganese and chromium in in vitro and in vivo experiments. Voprosy pitaniia [Problems of Nutrition]. 2007; 76 (5): 74–9. (in Russian)

24. Zorin S.N. Preparation and physico-chemical characterization of complexes of essential trace elements (zinc, copper, manganese, chromium) with enzymatic hydrolysates of food proteins. Mikroelementy v meditsine [Trace Elements in Medicine]. 2007; 8 (1): 53–5. (in Russian)

25. Chen W., Nishimura N., Oda H., Yokogoshi H. Effect of taurine on cholesterol degradation and bile acid pool in rats fed a high-cholesterol diet. Adv Exp Med Biol. 2003; 526: 261–7. DOI: https://doi.org/10.1007/978-1-4615-0077-3_33

26. Morsy M.D., Aboonq M.S., ALsleem M.A., Abusham A.A. Taurine prevents high-fat diet-induced-hepatic steatosis in rats by direct inhibition of hepatic sterol regulatory element-binding proteins and activation of AMPK. Clin Exp Pharmacol Physiol. 2020; 48: 72–85. DOI: https://doi.org/10.1111/1440-1681.13387

27. Dong Y., Li X., Liu Y., Gao J., Tao J. The molecular targets of taurine confer anti-hyperlipidemic effects. Life Sci. 2021; 278: 119579. DOI: https://doi.org/10.1016/j.lfs.2021.119579

28. Yokogoshi H., Mochizuki H., Nanami K., Hida Y., Miyachi F., Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr. 1999; 129: 1705–12. DOI: https://doi.org/10.1093/jn/129.9.1705

29. Tsuboyama-Kasaoka N., Shozawa C., Sano K., Kamei Y., Kasaoka S., Hosokawa Y., et al. Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology. 2006; 147: 3276–84. DOI: https://doi.org/10.1210/en.2005-1007

30. Lin S., Hirai S., Yamaguchi Y., Goto T., Takahashi N., Tani F. et al. Taurine improves obesity-induced inflammatory responses and modulates the unbalanced phenotype of adipose tissue macrophages. Mol Nutr Food Res. 2013; 57 (12): 2155–65. DOI: https://doi.org/10.1002/mnfr.201300150

31. Rosenberg I.M. Protein Analysis and Purification: Benchtop Techniques. Springer Science ± Business Media, 1996: 520 р. DOI: https://doi.org/10.1007/978-1-4757-1108-0

32. Dawson R., Elliot D., Elliot W., Jones K. Handbook of Biochemistry: Transl. from Engl. Moscow: Mir, 1991: 544 p. (in Russian)

33. Method 999.11, AOAC. Official Method of Analytical Chemists. 17th ed. Maryland, USA: Association of Official Analytical Chemists, 2000.

34. Tagawa R., Kobayashi M., Sakurai M., Yoshida M., Kaneko H., Mizunoe Y., et al. Long-term dietary taurine lowers plasma levels of cholesterol and bile acids. Int J Mol Sci. 2022; 23 (3): 1793. DOI: https://doi.org/10.3390/ijms 23031793

35. Inam-U-Llah, Piao F., Aadil R.M., Suleman R., Li K., Zhang M., et al. Ameliorative effects of taurine against diabetes: A review. Amino Acids. 2018; 50 (5): 487–502. DOI: https://doi.org/10.1007/s00726-018-2544-4

36. Morsy M.D., Aboonq M.S., ALsleem M.A., Abusham A.A. Taurine prevents high-fat diet-induced-hepatic steatosis in rats by direct inhibition of hepatic sterol regulatory element-binding proteins and activation of AMPK. Clin Exp Pharmacol Physiol. 2020; 48 (1): 72–85. DOI: https://doi.org/10.1111/1440-1681.13387

37. Dong Y., Li X., Liu Y., Gao J., Tao J. The molecular targets of taurine confer anti-hyperlipidemic effects. Life Sci. 2021; 278: 119579. DOI: https://doi.org/10.1016/j.lfs.2021.119579

38. Yokogoshi H., Mochizuki H., Nanami K., Hida Y., Miyachi F., Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr. 1999; 129 (9): 1705–12. DOI: https://doi.org/10.1093/jn/129.9.1705

39. Wojcik O.P., Koenig K.L., Zeleniuch-Jacquotte A., Costa M., Chen Y. The potential protective effects of taurine on coronary heart disease. Atherosclerosis. 2010; 208 (1): 19–25. DOI: https://doi.org/10.1016/j.atherosclerosis.2009.06.002

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

SCImago Journal & Country Rank
Scopus CiteScore
CHIEF EDITOR
CHIEF EDITOR
Viktor A. Tutelyan
Full Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor, Scientific Director of the Federal Research Centre of Nutrition, Biotechnology and Food Safety (Moscow, Russia)

Journals of «GEOTAR-Media»